These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23231394)

  • 1. Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function?
    Mousseau DD; Baker GB
    Curr Top Med Chem; 2012; 12(20):2163-76. PubMed ID: 23231394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs related to monoamine oxidase activity.
    Fišar Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
    Naoi M; Riederer P; Maruyama W
    J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs.
    Ramesh M; Muthuraman A
    Comb Chem High Throughput Screen; 2020; 23(9):887-897. PubMed ID: 32208114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Curr Top Med Chem; 2012; 12(20):2177-88. PubMed ID: 23231395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Specific Detection and Inhibition of Monoamine Oxidases and Their Applications in Central Nervous System Diseases.
    Shi R; Wu Q; Xin C; Yu H; Lim KL; Li X; Shi Z; Zhang CW; Qian L; Li L; Huang W
    Chembiochem; 2019 Jun; 20(12):1487-1497. PubMed ID: 30664830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.
    Naoi M; Maruyama W; Inaba-Hasegawa K; Akao Y
    Int Rev Neurobiol; 2011; 100():85-106. PubMed ID: 21971004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms.
    Mathew B; Suresh J; Mathew GE; Parasuraman R; Abdulla N
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):28-33. PubMed ID: 25142815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters.
    Adjou KT; Dilda P; Aumond P; Gueddari S; Deslys JP; Dormont D; Seman M
    Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors.
    Secci D; Carradori S; Bolasco A; Bizzarri B; D'Ascenzio M; Maccioni E
    Curr Top Med Chem; 2012; 12(20):2240-57. PubMed ID: 23276158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SENSITIVITY OF LIVER MONOAMINE OXIDASE IN THE LAMPREY LAMPETRA FLUVIATILIS TO SOME TRICYCLIC COMPOUNDS].
    Basova LN; Basova NE; Suvorov AA; Yagodina OV
    Zh Evol Biokhim Fiziol; 2015; 51(3):163-9. PubMed ID: 26281218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor design for monoamine oxidases.
    Ramsay RR
    Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular aspects of monoamine oxidase B.
    Ramsay RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():81-9. PubMed ID: 26891670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiplicity of mitochondrial monoamine exidases and ways of selective blocking of the enzyme activity].
    Severina IS
    Biokhimiia; 1976 Jul; 41(6):955-67. PubMed ID: 829219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity.
    Brooks AF; Shao X; Quesada CA; Sherman P; Scott PJ; Kilbourn MR
    ACS Chem Neurosci; 2015 Dec; 6(12):1965-71. PubMed ID: 26393369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.